仿真抗原受体自然杀手细胞疗法的进展:从机制和临床前研究到临床应用
Tianyuan Ren1, Fengjiang Wang1, Xuan Liu1
1ShanDong YinFeng Academy of Life Science, Jinan, Shandong, China.
Frontiers in oncology
|February 4, 2026
概括
自然杀手 (NK) 细胞疗法为癌症治疗提供了CAR-T疗法的一个有希望的替代方案. CAR-NK细胞在安全性,生产性和有效性方面具有优势,特别是在固体瘤中,目前正在进行的临床试验正在探索它们的潜力.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法改变了癌症治疗,但面临成本,安全性和固体瘤疗效等局限性.
- 自然杀手 (NK) 细胞提供了一种替代免疫疗法,具有天生的瘤杀死能力,多样化的细胞来源,并降低了移植与宿主疾病和细胞因子释放综合征的风险.
- NK细胞为"现成"的全源细胞疗法提供了潜力,克服了自主CAR-T方法的局限性.
研究的目的:
- 审查CAR-NK疗法的最新进展,包括工程策略,临床前模型和临床试验到2025年.
- 要突出独特的CAR-NK优化技术,使其与CAR-T有所区别.
- 批判性地分析CAR-NK开发和应用的挑战和潜在解决方案.
主要方法:
- 关于CAR-NK疗法的最新科学文献的综合.
- 专注于NK特定的CAR工程,血液和固体恶性瘤的临床前数据以及临床试验结果.
- 分析CAR-NK优化策略,包括Fc结合域,细胞因子装甲和克服瘤微环境抵抗.
主要成果:
- 与CAR-T相比,CAR-NK平台包含了不同的优化策略.
- 临床前模型表明在各种癌症中有效,目前正在进行的临床试验评估安全性和有效性.
- 确定的主要挑战包括体外扩张,制造可扩展性,体内持久性和瘤微环境耐药性.
结论:
- CAR-NK疗法是一个快速发展的领域,具有作为下一代免疫疗法的巨大潜力.
- 解决扩张,制造,持久性和TME耐药性的挑战对于临床翻译至关重要.
- CAR-NK是一种有前途的治疗方式,有可能克服当前CAR-T治疗的局限性.
相关概念视频
01:28Diversity of Antigen Receptors
1.6K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.6K
01:19Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
01:31Transducer Mechanism: Nuclear Receptors
2.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.5K
01:22Antigen Presenting Cells
3.3K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.3K
01:30Transducer Mechanism: G Protein–Coupled Receptors
4.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.0K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.0K